TGFB1 and non-small cell lung carcinoma: On the basis of these published findings, we investigated whether these functional genetic variants of TGFβ1 also affect tumor response and outcome in patients with inoperable NSCLC treated with definitive radiation or radiochemotherapy, assessed in terms of overall survival (OS) and distant metastasis–free survival (DMFS).